Comparing SBRT to CRT in Patients With Spinal Metastases
Prospective Registry Trail COMparing Stereotactic Body Radiotherpy (SBRT) to Conventional PAlliative RadioTherapy (CRT) in Patients With Spinal Metastases
University Health Network, Toronto
100 participants
Dec 12, 2022
OBSERVATIONAL
Conditions
Summary
This is a single institutional registry-based, prospective, observational study to describe radiation oncologists' decision making during evaluation of patients and to compare real-world outcomes of SBRT vs CRT. A registry-based trial involves observing the effect of something without manipulating it.
Eligibility
Inclusion Criteria5
- Adults 18 years of age or older.
- Patients seen at the Princess Margaret Cancer Centre with painful spinal metastases amenable to radiation treatment.
- Confirmation of diagnosis: a) Known/documented prior histological cancer diagnosis
- Able to provide written consent
- ECOG performance status 0-3
Exclusion Criteria2
- Prior radiotherapy, with fields overlapping, resulting in excessive doses to organs at risk
- Lymphoma, myeloma or germ cell malignancies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Standard of care radiotherapy administered as per institutional guidelines.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05589701